| Literature DB >> 22692288 |
Nadia Ovchinsky1, Roger K Moreira, Jay H Lefkowitch, Joel E Lavine.
Abstract
Liver biopsy remains the foundation of evaluation and management of liver disease in children, although the role of the liver biopsy is changing with development of alternative methods of diagnosis and advancement of hepatic imaging techniques. The indications for liver biopsy are evolving as current knowledge of etiologies, noninvasive biomarker alternatives, and treatment options in pediatric liver disease are expanding. The procedure can often be complicated in children by technical difficulties, cost, and smaller specimen size. Communication and partnership of clinicians with pathologists experienced in pediatric liver diseases are essential. DNA sequencing, novel imaging modalities, noninvasive biomarkers of fibrosis and apoptosis, proteomics, and genome-wide association studies offer potential alternative methods for evaluation of liver disease in children. This review presents specific indications, considerations, methods, complications, contraindications, and alternatives for pediatric liver biopsy.Entities:
Mesh:
Year: 2012 PMID: 22692288 PMCID: PMC3404724 DOI: 10.1097/PAP.0b013e31825c6a20
Source DB: PubMed Journal: Adv Anat Pathol ISSN: 1072-4109 Impact factor: 3.875